Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market: Competitive Intelligence and Tracking Report 2018 – 2026


                

The paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired bone marrow failure disorder, which leads to premature death and impaired red blood cells (RBCs). PNH is characterized by hemolytic anemia, thrombosis, and peripheral blood cytopenia.